Prestige Consumer Healthcare (NYSE:PBH) versus Demant A/S (OTCMKTS:WILYY) Head-To-Head Comparison

Prestige Consumer Healthcare (NYSE:PBH) and Demant A/S (OTCMKTS:WILYY) are both mid-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, valuation, dividends, analyst recommendations, earnings, profitability and risk.

Profitability

This table compares Prestige Consumer Healthcare and Demant A/S’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Prestige Consumer Healthcare	19.02%	12.69%	6.79%
Demant A/S	N/A	N/A	N/A

Earnings and Valuation

This table compares Prestige Consumer Healthcare and Demant A/S”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Prestige Consumer Healthcare	$1.11 billion	2.59	$214.60 million	$4.03	14.84
Demant A/S	$3.25 billion	2.08	$346.11 million	N/A	N/A

Demant A/S has higher revenue and earnings than Prestige Consumer Healthcare.

Analyst Ratings

This is a breakdown of current recommendations for Prestige Consumer Healthcare and Demant A/S, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Prestige Consumer Healthcare	0	4	4	0	2.50
Demant A/S	0	1	0	1	3.00

Prestige Consumer Healthcare presently has a consensus price target of $85.33, suggesting a potential upside of 42.71%. Given Prestige Consumer Healthcare’s higher possible upside, research analysts plainly believe Prestige Consumer Healthcare is more favorable than Demant A/S.

Institutional and Insider Ownership

99.9% of Prestige Consumer Healthcare shares are owned by institutional investors. 1.4% of Prestige Consumer Healthcare shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Risk and Volatility

Prestige Consumer Healthcare has a beta of 0.39, indicating that its stock price is 61% less volatile than the S&P 500. Comparatively, Demant A/S has a beta of 1.05, indicating that its stock price is 5% more volatile than the S&P 500.

Summary

Prestige Consumer Healthcare beats Demant A/S on 8 of the 13 factors compared between the two stocks.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear wax removals, and Dramamine for motion sickness relief. The company also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Summer's Eve feminine hygiene, TheraTears dry eye relief, Fess nasal saline spray and washes, and Hydralyte for oral rehydration products. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.

About Demant A/S

Demant A/S operates as a hearing healthcare and audio technology company in Europe, North America, the Asia Pacific, Asia, and internationally. It operates through two segments: Hearing Healthcare and Communications. The Hearing Healthcare segment is involved in the manufacturing, servicing, and sale of hearing aids, and diagnostic products and services. The Communications segment provides headsets and solutions for the professional call centers, office markets, and gaming markets under the EPOS brand name. The company was formerly known as William Demant Holding A/S and changed its name to Demant A/S in March 2019. Demant A/S was founded in 1904 and is headquartered in Smørum, Denmark.